Clarendon Private’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18M Buy
60,198
+21,758
+57% +$834K 1.67% 15
2025
Q4
$1.48M Buy
38,440
+15,647
+69% +$588K 1.25% 18
2025
Q3
$825K Buy
+22,793
New +$796K 0.75% 36

Other funds holding QLTY

Clarendon Private's QLTY Position: Q1 2026 in Review

Clarendon Private increased its GMO US Quality ETF (QLTY) stake by 57% in Q1 2026, buying an estimated $834K and bringing the position to 60,198 shares worth $2.18M. The position accounts for 1.67% of the portfolio, ranked #15.

Clarendon Private first reported a position in QLTY in Q3 2025 and has held it in 3 quarters since. 149 funds tracked by Wall St. Rank hold QLTY as of Q1 2026.

  • Clarendon Private held 60,198 shares of GMO US Quality ETF worth $2.18M as of Q1 2026.
  • Clarendon Private bought 21,758 GMO US Quality ETF shares in Q1 2026, an estimated $834K.
  • GMO US Quality ETF made up 1.67% of Clarendon Private's portfolio in Q1 2026, its #15 holding.
  • Clarendon Private first reported a position in GMO US Quality ETF in Q3 2025 and has held it in 3 quarters since.
  • 149 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q1 2026.

Based on Clarendon Private's 13F filing for Q1 2026, filed 11 May 2026.